ISB News

New York Times’ Matt Richtel on the ‘Elegant’ Immune System

In the first ISB-Town Hall Seattle Science Series of 2022, ISB President Dr. Jim Heath sat down with New York Times Pulitzer Prize winning reporter and bestselling author Matt Richtel for a wide ranging discussion that touched on the incredible immune system, distracted driving, social isolation, and much more. You can watch the hour-long fireside chat by clicking play on the video above. 

About the Science Series 

ISB and Town Hall Seattle have put on a number of virtual events focusing on a range of important scientific issues: The state of the microbiome field, the new science of longevity, why we age (and why we don’t have to), the importance of getting kids outside, STEM policy and advocacy, the politics of immunization, mining sewage to track population health, creating new senses for humans, and more. 

We will continue creating compelling events. To make sure you know of upcoming conversations, please follow us on Facebook, Twitter, LinkedIn and Instagram, and be sure to sign up for our newsletter for event updates.

Recent Articles

  • 2024 Year in Review

    Reflecting on the past year, ISB has a lot to celebrate: groundbreaking research published in leading scientific journals, well-earned promotions, widespread media coverage, and more. Enjoy our year-in-review roundup highlighting some of the important, interesting, and impactful highlights of 2024.

  • My Digital Gut

    ISB Named Winner of 2024-2025 Amazon Web Services IMAGINE Grant for Nonprofits

    ISB has been selected as a winner of the 2024 Amazon Web Services (AWS) IMAGINE Grant. The grant will support ISB’s continued development of My Digital Gut, an online decision-support platform that will help make microbiome-informed nutrition and healthcare personalized, predictive, and preventive. 

  • ISB-Developed MetaboCore Offers Precision Cancer Care Faster Than Ever 

    ISB Associate Professor Dr. Wei Wei and his colleagues have developed a promising new companion diagnostic tool called MetaboCore to help physicians quickly select the most effective systemic therapy for each cancer patient.